Publications by authors named "Neil Josephson"

Claim this Profile
R
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States.
Jill M Johnsen, Shelley N Fletcher, Angela Dove, Haley McCracken, Beth K Martin, Neil C Josephson

J Thromb Haemost· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
Barbara A Konkle, Christopher E Walsh, Miguel A Escobar, Neil C Josephson, Guy Young

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma.
Ann S LaCasce, R Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura, Neil Josephson

Br J Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.
Thomas E Delea, Arati Sharma, Aaron Grossman, Caitlin Eichten, Keenan Fenton, Neil Josephson

J Med Econ· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.
Ann S LaCasce, R Gregory Bociek, Ahmed Sawas, Paolo Caimi, Edward Agura, Neil Josephson

Blood· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
Costantine Albany, Lawrence Einhorn, Lawrence Garbo, Thomas Boyd, Neil Josephson

Oncologist· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Joseph M Connors, Wojciech Jurczak, David J Straus, Stephen M Ansell, Won S Kim, Neil C Josephson

N Engl J Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
Machaon Bonafede, Akshara Richhariya, Qian Cai, Neil C Josephson, Donna McMorrow

J Med Econ· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Economic Burden Associated with Transplantation-Related Complications.
Miguel-Angel Perales, Machaon Bonafede, Qian Cai, Phillip M Garfin, Donna McMorrow, Neil C Josephson

Biol Blood Marrow Transplant· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.
Jill M Johnsen, Shelley N Fletcher, Haley Huston, Sarah Roberge, Beth K Martin, Neil C Josephson

Blood Adv· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative management of factor XI deficiency with therapeutic plasma exchange: A case report and literature review.
Monica B Pagano, Barbara A Konkle, Yanyun Wu, Neil Josephson

J Clin Apher· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.
Uma Borate, Amitkumar Mehta, Vishnu Reddy, Michaela Tsai, Neil Josephson

Leuk Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice.
Sriram Krishnamoorthy, Tongyao Liu, Douglas Drager, Susannah Patarroyo-White, Ekta Seth Chhabra, Neil Josephson

Cell Immunol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study.
Jerry S Powell, Shashikant Apte, Hervé Chambost, Cedric Hermans, Shannon Jackson, Neil C Josephson

Br J Haematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hemophilias and their clinical management.
Neil Josephson

Hematology Am Soc Hematol Educ Program· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Johnny Mahlangu, Jerry S Powell, Margaret V Ragni, Pratima Chowdary, Neil C Josephson

Blood· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
Kenneth B Lewis, Richard J Hughes, Melinda S Epstein, Neil C Josephson, Christine L Kempton

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
Jerry S Powell, K John Pasi, Margaret V Ragni, Margareth C Ozelo, Leonard A Valentino, Neil C Josephson

N Engl J Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance.
Camille E Puronen, Neil C Josephson, Virginia C Broudy

Blood Coagul Fibrinolysis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
Jerry S Powell, Neil C Josephson, Doris Quon, Margaret V Ragni, Gregory Cheng

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.
Amy D Shapiro, Margaret V Ragni, Leonard A Valentino, Nigel S Key, Neil C Josephson

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of the androgen receptor via MS-compatible purification of biotinylated protein on streptavidin resin.
Ryan J Austin, Heidi M Smidansky, Carly A Holstein, Deborah K Chang, Angela Epp, Neil C Josephson

Proteomics· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells.
Rui-Jun Su, Angela Epp, Junli Feng, Jackie Roy, Yvette Latchman, Neil C Josephson

Mol Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of foamy virus vector and transduction of hematopoietic cells.
Neil C Josephson, David W Russell

Cold Spring Harb Protoc· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblasts.
Rui-Jun Su, Angela Epp, Yvette Latchman, Doug Bolgiano, Steven W Pipe, Neil C Josephson

Mol Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis